How should eosinophilic cystitis be treated in patients with chronic granulomatous disease?

Alessia Claps, Martina della Corte, Simona Gerocarni Nappo, Paola Francalanci, Paolo Palma, Andrea Finocchi

Research output: Contribution to journalArticlepeer-review


Background: Chronic granulomatous disease (CGD) is a primary immunodeficiency resulting from the absence or malfunction of oxidative mechanism in phagocytic cells. The disease is due to a mutation in one of four genes that encode subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. Affected patients experience severe infections and granuloma formation due to exuberant inflammatory responses. Some evidence suggests that eosinophilic cystitis (EC) is included in the spectrum of inflammatory manifestations. EC is an inflammatory disease, rare in childhood, which may require different, nonstandardized therapeutic approaches, ranging from antihistamines to cyclosporine.

Case-Diagnosis/Treatment: Herein we describe the cases of two CGD patients with CGD who experienced EC during hospitalization for a severe infection.

Conclusions: EC in immunocompetent children seems to have a self-limiting course, unlike in CGD patients, in whom it presents a prolonged and recurrent course. We focus on the effective therapy administered to our patients with CGD and review the corresponding literature.

Original languageEnglish
Pages (from-to)2229-2233
Number of pages5
JournalPediatric Nephrology
Issue number11
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)


Dive into the research topics of 'How should eosinophilic cystitis be treated in patients with chronic granulomatous disease?'. Together they form a unique fingerprint.

Cite this